ACADIA HEALTHCARE CO INC (ACHC) Fundamental Analysis & Valuation

NASDAQ:ACHC • US00404A1097

Current stock price

28.26 USD
+0.68 (+2.47%)
At close:
27.5 USD
-0.76 (-2.69%)
Pre-Market:

This ACHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ACHC Profitability Analysis

1.1 Basic Checks

  • In the past year ACHC was profitable.
  • ACHC had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
  • Each year in the past 5 years ACHC had a positive operating cash flow.
ACHC Yearly Net Income VS EBIT VS OCF VS FCFACHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • ACHC has a Return On Assets of -19.95%. This is in the lower half of the industry: ACHC underperforms 78.00% of its industry peers.
  • ACHC's Return On Equity of -56.58% is on the low side compared to the rest of the industry. ACHC is outperformed by 72.00% of its industry peers.
  • ACHC's Return On Invested Capital of 6.00% is fine compared to the rest of the industry. ACHC outperforms 63.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ACHC is in line with the industry average of 8.40%.
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROIC 6%
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ACHC Yearly ROA, ROE, ROICACHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • Looking at the Operating Margin, with a value of 11.71%, ACHC belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ACHC has declined.
  • The Profit Margin and Gross Margin are not available for ACHC so they could not be analyzed.
Industry RankSector Rank
OM 11.71%
PM (TTM) N/A
GM N/A
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHC Yearly Profit, Operating, Gross MarginsACHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

2

2. ACHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACHC is destroying value.
  • Compared to 1 year ago, ACHC has less shares outstanding
  • ACHC has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ACHC is higher compared to a year ago.
ACHC Yearly Shares OutstandingACHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ACHC Yearly Total Debt VS Total AssetsACHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.14, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.14, ACHC is doing worse than 66.00% of the companies in the same industry.
  • A Debt/Equity ratio of 1.27 is on the high side and indicates that ACHC has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.27, ACHC is doing worse than 67.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACC0.71
WACC8.44%
ACHC Yearly LT Debt VS Equity VS FCFACHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that ACHC should not have too much problems paying its short term obligations.
  • ACHC has a Current ratio (1.55) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.54 indicates that ACHC should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.54, ACHC is doing good in the industry, outperforming 64.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.54
ACHC Yearly Current Assets VS Current LiabilitesACHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

3

3. ACHC Growth Analysis

3.1 Past

  • The earnings per share for ACHC have decreased strongly by -30.42% in the last year.
  • The Earnings Per Share has been decreasing by -6.12% on average over the past years.
  • Looking at the last year, ACHC shows a small growth in Revenue. The Revenue has grown by 5.04% in the last year.
  • The Revenue has been growing by 9.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-30.42%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-7.5%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%7.57%

3.2 Future

  • Based on estimates for the next years, ACHC will show a decrease in Earnings Per Share. The EPS will decrease by -1.96% on average per year.
  • The Revenue is expected to grow by 6.26% on average over the next years.
EPS Next Y-24.92%
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%
EPS Next 5Y-1.96%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACHC Yearly Revenue VS EstimatesACHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
ACHC Yearly EPS VS EstimatesACHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. ACHC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.20, ACHC is valued correctly.
  • Based on the Price/Earnings ratio, ACHC is valued cheaper than 86.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.54. ACHC is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 16.37, ACHC is valued correctly.
  • 68.00% of the companies in the same industry are more expensive than ACHC, based on the Price/Forward Earnings ratio.
  • ACHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.2
Fwd PE 16.37
ACHC Price Earnings VS Forward Price EarningsACHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ACHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ACHC is cheaper than 78.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.63
ACHC Per share dataACHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ACHC's earnings are expected to decrease with -2.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%

0

5. ACHC Dividend Analysis

5.1 Amount

  • ACHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACHC Fundamentals: All Metrics, Ratios and Statistics

ACADIA HEALTHCARE CO INC

NASDAQ:ACHC (4/29/2026, 8:00:00 PM)

Premarket: 27.5 -0.76 (-2.69%)

28.26

+0.68 (+2.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength59.63
Industry Growth65.84
Earnings (Last)04-29
Earnings (Next)N/A
Inst Owners133.55%
Inst Owner Change1.6%
Ins Owners0.96%
Ins Owner Change4.15%
Market Cap2.60B
Revenue(TTM)3.31B
Net Income(TTM)-1.10B
Analysts74
Price Target24.37 (-13.77%)
Short Float %24.41%
Short Ratio6.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.79%
Min EPS beat(2)5.25%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)12.66%
Min EPS beat(4)5.25%
Max EPS beat(4)18.32%
EPS beat(8)6
Avg EPS beat(8)5.22%
EPS beat(12)10
Avg EPS beat(12)4.68%
EPS beat(16)13
Avg EPS beat(16)10.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)1.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.64%
PT rev (1m)20.15%
PT rev (3m)8.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.6%
EPS NY rev (1m)0.94%
EPS NY rev (3m)-22.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 14.2
Fwd PE 16.37
P/S 0.79
P/FCF N/A
P/OCF 19.72
P/B 1.33
P/tB 4.68
EV/EBITDA 8.63
EPS(TTM)1.99
EY7.04%
EPS(NY)1.73
Fwd EY6.11%
FCF(TTM)-4.78
FCFYN/A
OCF(TTM)1.43
OCFY5.07%
SpS36
BVpS21.18
TBVpS6.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.7932 (8.96%)
Profitability
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROCE 7.76%
ROIC 6%
ROICexc 6.16%
ROICexgc 8.63%
OM 11.71%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ROICexc(3y)7.58%
ROICexc(5y)7.53%
ROICexgc(3y)13.72%
ROICexgc(5y)14.49%
ROCE(3y)9.6%
ROCE(5y)9.52%
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-7.02%
ROICexc growth 5Y2.87%
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 4.3
Cap/Depr 302.15%
Cap/Sales 17.26%
Interest Coverage 3.11
Cash Conversion 22.85%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.54
Altman-Z 1.14
F-Score5
WACC8.44%
ROIC/WACC0.71
Cap/Depr(3y)361.37%
Cap/Depr(5y)312.98%
Cap/Sales(3y)17.88%
Cap/Sales(5y)15.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.42%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-7.5%
EPS Next Y-24.92%
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%
EPS Next 5Y-1.96%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%7.57%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%
EBIT growth 1Y-25.72%
EBIT growth 3Y-4.55%
EBIT growth 5Y3.12%
EBIT Next Year46.21%
EBIT Next 3Y18%
EBIT Next 5Y20.08%
FCF growth 1Y21.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.7%
OCF growth 3Y-29.76%
OCF growth 5Y-25.73%

ACADIA HEALTHCARE CO INC / ACHC Fundamental Analysis FAQ

What is the fundamental rating for ACHC stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACHC.


What is the valuation status for ACHC stock?

ChartMill assigns a valuation rating of 3 / 10 to ACADIA HEALTHCARE CO INC (ACHC). This can be considered as Overvalued.


What is the profitability of ACHC stock?

ACADIA HEALTHCARE CO INC (ACHC) has a profitability rating of 3 / 10.


What is the valuation of ACADIA HEALTHCARE CO INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ACADIA HEALTHCARE CO INC (ACHC) is 14.2 and the Price/Book (PB) ratio is 1.33.


What is the financial health of ACADIA HEALTHCARE CO INC (ACHC) stock?

The financial health rating of ACADIA HEALTHCARE CO INC (ACHC) is 2 / 10.